19th February 2014
At the moment, Organovo is synonymous with bioprinting in the 3D printing world. The San Diego–based company will begin selling its printed, living liver tissue later this year to the pharmaceutical industry, which can use it to test new drugs.
But other institutions are hot on Organovo’s trail. Scientists at the Harvard Wyss Institute for Biologically Inspired Engineering announced Wednesday that they have successfully printed multiple types of cells and blood vessels, a combination that is necessary to create more complex tissue. They published their work in Advanced Materials (subscription required). A visual walkthrough of their method is available here.